Metabolic Health

Compounds studied in glucose metabolism, insulin sensitivity, lipid profiles, or body composition. Showing 6 compounds.

← All categories
GHRP-6 Growth hormone releasing peptide studied in GH secretion and metabolic effects. View research notes → Ipamorelin / CJC-1295 GHRP + GHRH analog pair studied in growth hormone release and lean body composition. View research notes → MOTS-c Mitochondria-encoded peptide studied as an insulin sensitizer and metabolic regulator. View research notes → NAD+ Coenzyme studied in metabolic function, mitochondrial health, and glucose metabolism. View research notes → Semaglutide FDA-approved GLP-1 agonist studied in glycemic control and metabolic risk reduction. View research notes → Tirzepatide FDA-approved dual agonist with the strongest metabolic outcomes in current trials. View research notes → CJC-1295 CJC-1295 is a synthetic 29-amino acid peptide designed to mimic and extend the activity of endogenous growth hormone-releasing hormone (GHRH), the hypothalamic signal that instructs the pituitary to release growth hormone. View research notes → IGF-1 LR3 IGF-1 LR3, also written Long R3 IGF-I, is an 83-amino acid synthetic analog of human insulin-like growth factor-1 (IGF-1). View research notes → Retatrutide Retatrutide is a synthetic peptide developed by Eli Lilly that acts as a single-molecule agonist at three distinct hormone receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor. View research notes → Tesamorelin Tesamorelin is a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH), the hypothalamic peptide that signals the anterior pituitary to release growth hormone. View research notes → Cagrilintide Cagrilintide is a long-acting synthetic analog of amylin, a peptide hormone that is co-secreted with insulin from pancreatic beta cells. View research notes →